NM_004070.4:c.1005C>T
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_004070.4(CLCNKA):c.1005C>T(p.Leu335Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00311 in 1,614,140 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0032 ( 12 hom. )
Consequence
CLCNKA
NM_004070.4 synonymous
NM_004070.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.43
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BP6
Variant 1-16028797-C-T is Benign according to our data. Variant chr1-16028797-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 447079.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.43 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 12 AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKA | NM_004070.4 | c.1005C>T | p.Leu335Leu | synonymous_variant | Exon 11 of 20 | ENST00000331433.5 | NP_004061.3 | |
CLCNKA | NM_001042704.2 | c.1005C>T | p.Leu335Leu | synonymous_variant | Exon 11 of 20 | NP_001036169.1 | ||
CLCNKA | NM_001257139.2 | c.876C>T | p.Leu292Leu | synonymous_variant | Exon 10 of 19 | NP_001244068.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00189 AC: 288AN: 152224Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
288
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00173 AC: 436AN: 251384Hom.: 0 AF XY: 0.00190 AC XY: 258AN XY: 135894
GnomAD3 exomes
AF:
AC:
436
AN:
251384
Hom.:
AF XY:
AC XY:
258
AN XY:
135894
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00324 AC: 4732AN: 1461798Hom.: 12 Cov.: 32 AF XY: 0.00320 AC XY: 2329AN XY: 727194
GnomAD4 exome
AF:
AC:
4732
AN:
1461798
Hom.:
Cov.:
32
AF XY:
AC XY:
2329
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00189 AC: 288AN: 152342Hom.: 1 Cov.: 33 AF XY: 0.00152 AC XY: 113AN XY: 74490
GnomAD4 genome
AF:
AC:
288
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
113
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Aug 12, 2020
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not specified Benign:1
Aug 18, 2016
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at